FGF23 Actions in CKD-MBD and other Organs During CKD.

Sun, Ting; Yu, Xijie

Sun, Ting; Yu, Xijie.

Affiliation

Sun T; Laboratory of Endocrinology and Metabolism, Department of Endocrinology and Metabolism, Rare Disease Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China.
Yu X; Laboratory of Endocrinology and Metabolism, Department of Endocrinology and Metabolism, Rare Disease Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China.

Curr Med Chem ; 30(7): 841-856, 2023.

Article in En | MEDLINE | ID: mdl-35761503

Subject(s)

Bone Diseases, Metabolic; Chronic Kidney Disease-Mineral and Bone Disorder; Fibroblast Growth Factor-23; Renal Insufficiency, Chronic; Humans; Bone Diseases, Metabolic/complications; Bone Diseases, Metabolic/metabolism; Chronic Kidney Disease-Mineral and Bone Disorder/complications; Phosphates; Phosphorus; Renal Insufficiency, Chronic/metabolism; Fibroblast Growth Factor-23/metabolism

Key words

CKD; CKD-MBD; FGF23; bone; cardiovascular; endothelium; kidney; parathyroid

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Chronic Kidney Disease-Mineral and Bone Disorder / Bone Diseases, Metabolic / Renal Insufficiency, Chronic / Fibroblast Growth Factor-23 Language: En Journal: Curr Med Chem Year: 2023 Type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google